Publications

5539 Results

Infusional interleukin-2 and 5-fluorouracil with subcutaneous intergeron-a for the treatment of patients with advanced renal cell carcinoma: A Southwest Oncology Group phase ll study.

Authors
L Elias;D Lew;RA Figlin;RC Flanigan;ME Thompson;PL Triozzi;RJ Belt;DP Wood;SE Rivkin;ED Crawford
Journal / Conference
Cancer 89(3):597-603
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9338

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

Authors
TR Chauncey;C Rankin;JE Anderson;I Chen;KJ Kopecky;JE Godwin;ME Kalaycio;DF Moore Jr;MS Shurafa;SH Petersdorf;EH Kraut;CP Leith;DR Head;FW Luthardt;CL Willman;FR Appelbaum
Journal / Conference
Leukemia Research 24:567-574
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
S9617

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR, and pS2 by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group study

Authors
RM Elledge;S Greem;R Pugh;DC Allred;GM Clark;J Hill;P Ravdin;S Martino;CK Osborne
Journal / Conference
International Journal of Cancer 89:111-117
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

A phase II study of high dose Ara-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. A Southwest Oncology Group study.

Authors
PJ Rosen;C Rankin;DR Head;DH Boldt;FW Luthardt;T Norwood;RP Pugh;C Karanes;FR Appelbaum
Journal / Conference
Leukemia Research 24:183-187
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9030

Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases.

Authors
CM Moinpour;B Lyons;SP Schmidt;K Chansky;RA Patchell
Journal / Conference
Quality of Life Research 9:219-231
Year
2000
Research Committee(s)
Brain
Study Number(s)
SWOG-9021 (INT-0124) (BTCG-9021) (RTOG-9021)

Androgen deprivation and four courses fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: a Southwest Oncology Group study

Authors
MHA Hussain;EI Fisher;DP Petrylak;J O'Connor;DP Wood;EJ Small;MA Eisenberger;ED Crawford
Journal / Conference
Journal of Clinical Oncology 18(5):1043-1049
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Maintenance Bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study

Authors
DL Lamm;BA Blumenstein;JD Crissman;JE Montie;JE Gottesman;BA Lowe;MF Sarosdy;RD Bohl;HB Grossman;TM Beck;JT Leimert;ED Crawford
Journal / Conference
Journal of Urology 163:124-1129
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation thereapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix

Authors
WA Peters III;PY Liu;RJ Barrett;RJ Stock;BJ Monk;JS Berek;L Souhami;P Grigsby;W Gordon Jr;DS Alberts
Journal / Conference
Journal of Clinical Oncology 18(8):1606-1613
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group study

Authors
SK WIlliamson;D Lew;GJ Miller;SP Balcerzak;LH Baker;ED Crawford
Journal / Conference
Cancer 88(5):1159-1165
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8925

A phase II trial of topotecan in esophageal carcinoma: A Southwest Oncology Group study (SWOG-9339)

Authors
JS Macdonald;JL Jacobson;SJ Ketchel;G Weiss;S Taylor;G Mills;JP Kuebler;S Rivkin;M Conrad
Journal / Conference
Investigational New Drugs 18:199-202
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9339